Feasibility of semiquantitative 18F-fluorodeoxyglucose PET/computed tomography in patients with advanced lung cancer for interim treatment evaluation of combining immunotherapy and chemotherapy.

Nucl Med Commun · 2021 · PMC8357040 · PMID 33899782

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

marginally statistically significantP = 0.058so close (0.05 < p ≤ 0.1)

At the same time, GLG and MTVwb were also higher in no-clinical benefit group than clinical benefit group, but this was marginally statistically significant (2830.04 ± 880.40 vs. 2365.57 ± 794.29, P = 0.058; 116.57 ± 139.19 vs. 61.55 ± 79.76, P = 0.078; respectively (Table 2 ).

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.